Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs

Author： Geutjes Ernst-Jan  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.131, Iss.3, 2012-02, pp. : 809-818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 331-335

Spandidos Publications

Access to resources Recommend Favorite

PIK3CA mutations in breast cancer are associated with poor outcome

By Li Shao   Rong Minna   Grieu Fabienne   Iacopetta Barry  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 91-95

Springer Publishing Company

Access to resources Recommend Favorite

DBC1 is over-expressed and associated with poor prognosis in colorectal cancer

By Zhang Yongguo   Gu Yong   Sha Sumei   Kong Xiangyun   Zhu Hongwu   Xu Bin   Li Yijun   Wu Kaichun  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 106-112

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy

By Kim Hee  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 777-788

Springer Publishing Company

Access to resources Recommend Favorite

Gli1 promotes cell survival and is predictive of a poor outcome in ERα-negative breast cancer

By Xu Lusheng  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 59-71

Springer Publishing Company

Access to resources Recommend Favorite